The KEAP1-NRF2 System in Cancer.
Taguchi K, Yamamoto M. · 2017
Read The KEAP1-NRF2 System in Cancer. by Taguchi K, Yamamoto M. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5415577.txt.
Description
Taguchi and Yamamoto review how a cell defense system can turn against the body in cancer. Their review appeared in Frontiers in Oncology. The system pairs two proteins, KEAP1 and NRF2. In healthy cells KEAP1 keeps NRF2 levels low. Stress signals switch KEAP1 off. NRF2 then builds up and turns on protective genes. Cancer cells can lock this switch in the on position.
Mutations in KEAP1 or NRF2 cause much of that lock-in. Other faults can break the pair apart as well. A stuck-on NRF2 shields cancer cells from drugs. It also shields them from reactive oxygen species. It further rewires how the cells use fuel. The authors weigh two drug strategies. Blocking NRF2 may help patients whose tumors depend on it. Boosting NRF2 may aid other diseases or pair with standard chemotherapy. Finding which tumors run hot on NRF2 is the key test.
Catalog record
| CREATOR | Taguchi K, Yamamoto M. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |